-
NUMBER OF INSIDER BUYING
(Last 12 Months)
0 -
NUMBER OF INSIDER SELLING
(Last 12 Months)
5 -
AMOUNT OF INSIDERS BUYING
(Last 12 Months)
$0 -
AMOUNT OF INSIDERS SELLING
(Last 12 Months)
$218,901
Nektar Therapeutics Insider Transactions
Nektar Therapeutics Insider Trades History
Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
---|---|---|---|---|---|---|---|
CHESS ROBERT
Director |
Sell | 19,500 @ $1.20 | $23,400 | 255,273 | 06/14/2024 | 06/14/2024 | |
Zalevsky Jonathan
Chief R&D Officer |
Sell | 7,355 @ $1.75 | $12,871 | 257,670 | 05/17/2024 | 05/20/2024 | |
ROBIN HOWARD W
CEO |
Sell | 16,650 @ $1.75 | $29,138 | 863,239 | 05/17/2024 | 05/20/2024 | |
Wilson Mark Andrew
Chief Legal Officer |
Sell | 6,260 @ $1.75 | $10,955 | 230,414 | 05/17/2024 | 05/20/2024 | |
Deep Track Capital, LP
10 percent owner |
Sell | 56,000 @ $1.78 | $99,630 | 18,344,000 | 05/10/2024 | 05/13/2024 | |
Zalevsky Jonathan
Chief R&D Officer |
Sell | 9,014 @ $0.68 | $6,130 | 265,025 | 02/20/2024 | 02/22/2024 | |
Wilson Mark Andrew
Chief Legal Officer |
Sell | 7,606 @ $0.68 | $5,172 | 236,674 | 02/20/2024 | 02/22/2024 | |
ROBIN HOWARD W
CEO |
Sell | 20,033 @ $0.68 | $13,622 | 879,889 | 02/20/2024 | 02/22/2024 | |
Zalevsky Jonathan
Chief R&D Officer |
Sell | 9,646 @ $0.49 | $4,727 | 274,039 | 11/17/2023 | 11/20/2023 | |
Wilson Mark Andrew
Chief Legal Officer |
Sell | 7,179 @ $0.49 | $3,518 | 243,780 | 11/17/2023 | 11/20/2023 | |
ROBIN HOWARD W
CEO |
Sell | 19,877 @ $0.49 | $9,740 | 899,922 | 11/17/2023 | 11/20/2023 | |
Curet Myriam
Director |
Sell | 4,359 @ $0.69 | $3,008 | 27,418 | 09/18/2023 | 09/20/2023 | |
Ajer Jeffrey Robert
Director |
Sell | 4,359 @ $0.69 | $3,008 | 34,153 | 09/18/2023 | 09/20/2023 | |
Zalevsky Jonathan
Chief R&D Officer |
Sell | 9,703 @ $0.78 | $7,568 | 283,685 | 08/16/2023 | 08/17/2023 | |
Wilson Mark Andrew
Chief Legal Officer |
Sell | 7,221 @ $0.78 | $5,632 | 250,959 | 08/16/2023 | 08/17/2023 | |
ROBIN HOWARD W
CEO |
Sell | 19,998 @ $0.78 | $15,598 | 919,799 | 08/16/2023 | 08/17/2023 | |
WHITFIELD ROY A
Director |
Sell | 30,000 @ $0.57 | $17,100 | 216,250 | 06/14/2023 | 06/15/2023 | |
Zalevsky Jonathan
Chief R&D Officer |
Sell | 9,791 @ $0.72 | $7,050 | 293,388 | 05/16/2023 | 05/17/2023 | |
Wilson Mark Andrew
Chief Legal Officer |
Sell | 7,543 @ $0.72 | $5,431 | 257,680 | 05/16/2023 | 05/17/2023 | |
ROBIN HOWARD W
CEO |
Sell | 20,361 @ $0.72 | $14,660 | 939,797 | 05/16/2023 | 05/17/2023 |
Nektar Therapeutics Frequently Asked Questions
-
Who is on Nektar Therapeutics's Insider Roster?
The list of insiders at Nektar Therapeutics includes ROBIN HOWARD W, Wilson Mark Andrew, Zalevsky Jonathan, Deep Track Capital, LP, CHESS ROBERT.
-
How much insider selling is happening at Nektar Therapeutics?
Insiders have sold a total of 179,120 Nektar Therapeutics shares in the last 12 months for a total of 218,901 sold.
-
Which Nektar Therapeutics insiders have been selling company stock?
The following insiders have sold Nektar Therapeutics shares in the last 12 months: ROBIN HOWARD W ($52,500), Wilson Mark Andrew ($19,645), Zalevsky Jonathan ($23,727), Deep Track Capital, LP ($99,630), CHESS ROBERT ($23,400),